October 23, 2014
As the Ebola outbreak continues with deadly momentum, drugmakers are working at lightning speed to develop a vaccine.
The current outbreak has killed nearly 5,000 people, with most of the deaths in hard-hit countries like Liberia, Sierra Leone and Guinea. But the World Health Organization (WHO) says that is likely a low estimate, and the actual death toll may be as high as 15,000.
WHO has called on Big Pharma to work with government agencies to speed the development of promising treatments and vaccines to help halt the spread of the disease, and the industry has responded. Plus,a new 200 million ($250 million) investment from Europe's public-private Innovative Medicines Initiative is expected to help finance clinical trials of vaccines.